Secondary buyers who jumped into $ANT on Nov.
Secondary buyers who jumped into $ANT on Nov. 19 are taking the brunt of this pullback, while Anthropic itself already locked in about $93.5 billion from the IPO. That split fits my bearish view on hyped AI lab valuations: the early pop rewards the issuer and IPO allocation holders, and leaves open-market buyers exposed once gravity kicks in.
- Anyone who bought ANT during its Nov. 19 session is in the red. After pricing at $83, shares opened at $111.50, touched about $115, and closed at $97.17, before dropping 11.68% to $85.82 in Nov. 20 premarket trading.
- Anthropic and its IPO buyers are in a very different spot. Reuters reported on Nov. 20 that underwriters exercised the greenshoe to push total proceeds to roughly $93.5 billion, and $85.82 still sits above the $83 offer price.
- Broader AI-trade investors are catching spillover too. Reuters reported Asian stocks are headed for their worst week since 2020, down about 8%, with Nasdaq 100 futures lower as valuation doubts and hawkish Fed signals outweighed Nvidia's strong results earlier in the week.
I still think Anthropic survives as a front-runner even through a sharp post-IPO hangover. Until revenue and profit growth prove they can carry this kind of valuation, the people buying after the opening bell carry most of the risk.
Sources:
Reuters: https://www.reuters.com/business/finance/anthropic-ipo-haul-rises-935-billion-after-underwriters-exercise-greenshoe-2026-11-20/
CNBC: https://www.cnbc.com/amp/2026/11/20/stocks-moving-the-most-today-live-updates.html
The Guardian: https://www.theguardian.com/business/live/2026/nov/20/asia-stocks-worst-anthropic-ipo-ai-stock-market-latest-updates-news
Not financial advice. For informational and educational purposes only.
